Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Fluorodeoxyglucose (FDG) positron emission tomography (PET)
Magnetic resonance imaging (MRI)
+1 more
Locations
1
United States
University of California Davis Medical Center
Sacramento, California, United States
Start Date
April 30, 2016
Primary Completion Date
June 30, 2026
Completion Date
June 30, 2026
Last Updated
December 5, 2025
NCT06218589
NCT03151473
NCT07172997
NCT06168383
NCT05989711
NCT00666016
Lead Sponsor
University of California, Davis
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions